Sofinnova Partners Call for Ideas for innovative bio-tech startups
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability, with offices in Paris, London, and Milan, managing over €4 billion in assets and backing more than 500 companies globally. The firm operates a comprehensive life sciences platform spanning multiple stages and sectors, where Sofinnova Biovelocita fits as its pan-European strategy dedicated to creating and accelerating biotech startups, reinforcing Sofinnova’s acceleration pillar.
Following the launch of the Sofinnova Biovelocita Strategy in 2024, a first Call for Ideas was opened for Armenise Harvard Foundation Career Development Awardees (CDA), Armenise Harvard Airalzh Mid-Career Awardees (AHA-MCA), and Armenise Harvard INF-ACT Awardees (AHI-MCA).
We are pleased to announce the launch of a second Call for Ideas, reserved for Armenise Harvard Foundation–affiliated scientists based in Italy (CDA, AHA-MCA, and AHI-MCA). At the conclusion of the evaluation process, and at the sole discretion of Sofinnova Partners, selected projects may receive funding of up to €500,000 per project.
